Interventions for valvular disease Quantitative aortography assessment of aortic regurgitation. Insight into a novel technique Modolo R, Chang C, Onuma Y, Schultz C, Tateishi H, Abdelghani M, Miyazaki Y, Aben J-P, Rutten M, Pighi M, El Bouziani A, van Mourik M, Lemos P, Wykrzykowska J, Sandoli de Brito Jr F, Sahyoun C, Piazza N, Eltchaninoff H, Soliman O, Abdel-Wahab M, Van Mieghem N, de Winter R, Serruys P November 20, 2019 | 10.4244/EIJ-D-19-00879
TAVI and horizontal aorta: a "no impact" relationship? Abdel-Wahab M, Kitamura M, Thiele H October 4, 2019 | 10.4244/EIJV15I9A136
Coronary interventions Impact of target lesion location on procedural and angiographic outcomes of rotational atherectomy versus modified balloon angioplasty prior to drug-eluting stent implantation in severely calcified coronary lesions:a subgroup analysis of the PREPARE-CALC randomized trial Rheude T, Toelg R, Byrne R, Allali A, Wiebe J, Sulimov D, Voll F, Cassese S, Richardt G, Kastrati A, Abdel-Wahab M October 1, 2019 | 10.4244/EIJ-D-19-00488
Quantitative aortography for assessing aortic regurgitation after transcatheter aortic valve implantation: results of the multicentre ASSESS-REGURGE Registry Modolo R, Chang C, Tateishi H, Miyazaki Y, Pighi M, Abdelghani M, Roos M, Wolff Q, Wykrzykowska J, de Winter R, Piazza N, Richardt G, Abdel-Wahab M, Soliman O, Onuma Y, Van Mieghem N, Serruys P August 29, 2019 | 10.4244/EIJ-D-19-00362
TAVI and valve performance: update on definitions, durability, transcatheter heart valve failure modes and management Eltchaninoff H, Durand E, Barbanti M, Abdel-Wahab M September 7, 2018 | 10.4244/EIJ-D-18-00653
Interventions for valvular disease Computed tomography-based oversizing and incidence of paravalvular aortic regurgitation and permanent pacemaker implantation with a new-generation self-expanding transcatheter heart valve Kim U, Blanke P, Windecker S, Kasel A, Schäfer U, Walters D, Linke A, Le Breton H, Schymik G, Spence M, Søndergaard L, Abdel-Wahab M, Worthley S, Tchétché D, Reichenspurner H, Ohana M, Sellers S, Leipsic J August 3, 2018 | 10.4244/EIJ-D-17-01040
Interventions for valvular disease Long-term durability and haemodynamic performance of a self-expanding transcatheter heart valve beyond five years after implantation: a prospective observational study applying the standardised definitions of structural deterioration and valve failure Holy E, Kebernik J, Abdelghani M, Stampfli SF, Hellermann J, Allali A, El-Mawardy M, Sachse S, Lüscher T, Tanner F, Richardt G, Abdel-Wahab M July 20, 2018 | 10.4244/EIJ-D-18-00041
Interventions for valvular disease Transcatheter aortic valve implantation with the 34 mm self-expanding CoreValve Evolut R: initial experience in 101 patients from a multicentre registry Kuhn C, Frerker C, Meyer A-K, Kurz T, Schäfer U, Deuschl F, Abdel-Wahab M, Schewel D, Elghalban A, Kuck K, Frey N, Frank D June 14, 2018 | 10.4244/EIJ-D-17-01153
Interventions for valvular disease Impact of femoral artery puncture using digital subtraction angiography and road mapping on vascular and bleeding complications after transfemoral transcatheter aortic valve implantation El-Mawardy M, Schwarz B, Landt M, Sulimov DS, Kebernik J, Allali A, Becker B, Toelg R, Richardt G, Abdel-Wahab M January 20, 2017 | 10.4244/EIJ-D-15-00412
Interventions for valvular disease One-year outcomes with two suture-mediated closure devices to achieve access-site haemostasis following transfemoral transcatheter aortic valve implantation Mehilli J, Jochheim D, Abdel-Wahab M, Rizas K, Theiss H, Spenkuch N, Zadrozny M, Baquet M, El-Mawardy M, Sato T, Lange P, Kupatt C, Greif M, Hausleiter J, Bauer A, Schwarz F, Pichlmaier M, Hagl C, Richardt G, Massberg S November 20, 2016 | 10.4244/EIJV12I10A213
Interventions for valvular disease Redo TAVI: initial experience at two German centres Schmidt T, Frerker C, Alessandrini H, Schlüter M, Kreidel F, Schäfer U, Thielsen T, Kuck K, Jose J, Holy E, El-Mawardy M, Allali A, Richardt G, Abdel-Wahab M September 18, 2016 | 10.4244/EIJV12I7A144
Coronary interventions Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial Program Abdel-Wahab M, Neumann F-J, Serruys P, Silber S, Leon M, Mauri L, Yeung A, Belardi J, Widimsky P, Meredith I, Saito S, Richardt G July 20, 2016 | 10.4244/EIJY15M07_07
Coronary interventions Hybrid strategy with a bioresorbable scaffold and a drug-coated balloon for diffuse coronary artery disease: the “no more metallic cages” multicentre pilot experience Ielasi A, Miyazaki T, Geraci S, Testa L, Abdel-Wahab M, Kawamoto H, Ruparelia N, Sato T, Caramanno G, Bedogni F, Tespili M, Colombo A, Latib A April 8, 2016 | 10.4244/EIJV11I14A309
Interventions for valvular disease Transfemoral TAVI devices: design overview and clinical outcomes Abdel-Wahab M, Jose J, Richardt G September 17, 2015 | 10.4244/EIJV11SWA33
Selection of TAVI prostheses: do we really have the CHOICE? Abdel-Wahab M, Richardt G September 27, 2014 | 10.4244/EIJV10SUA5
Comparison of bivalirudin and heparin in patients undergoing rotational atherectomy: a subanalysis of the randomised ROTAXUS trial Akin I, Khattab A, Buettner H, Toelg R, Geist V, Neumann F-J, Richardt G, Abdel-Wahab M August 19, 2014 | 10.4244/EIJV10I4A79
Outcome of patients after emergency conversion from transcatheter aortic valve implantation to surgery Hein R, Abdel-Wahab M, Sievert H, Kuck K, Voehringer M, Hambrecht R, Sack S, Hauptmann K-E, Senges J, Zahn R, Mudra H August 23, 2013 | 10.4244/EIJV9I4A73
Stuck rotablator: the nightmare of rotational atherectomy Sulimov DS, Abdel-Wahab M, Toelg R, Kassner G, Geist V, Richardt G June 28, 2013 | 10.4244/EIJV9I2A41
Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry Abdel-Wahab M, Nienaber C, Naber C, Mostafa A, Sabin G, Tebbe U, Hochadel M, Senges J, Akin I, Kuck K, Hamm C, Richardt G June 30, 2011 | 10.4244/EIJV7I2A34
Haemodynamic evaluation of aortic regurgitation after transcatheter aortic valve implantation using cardiovascular magnetic resonance Sherif M, Abdel-Wahab M, Beurich H-W, Stöcker B, Zachow D, Geist V, Tölg R, Richardt G May 17, 2011 | 10.4244/EIJV7I1A12
New issue Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue (Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right)) December 6, 2019
Trials Book Discover 5 new trials: GALILEO, CONDI-2/ERIC-PCI, EVOLUTE II-5 years, SCOPE and Excel 5 years (The Trials book is supported by Biotronik) December 13, 2019
Editorial 2019 – A leap year for valvular heart disease (Course directors PCR London Valves 2019) November 15, 2019